| Biomarker ID | 906 |
| PMID | 22505341 |
| Year | 2012 |
| Biomarker | Fusion status of TMPRSS2-ERG and TERT expression |
| Biomarker Basis | Expression Based |
| Biomolecule | mRNA |
| Source | Urine |
| Subjects | Humans |
| Regulation | TMPRSS2–ERG and TERT-negative tumors had significantly lower rate of recurrence |
| Odds Ratio/Hazard Ratio/Relative Risk | HR: 7.33 (95% CI: 0.98-54.99) |
| Effect on Pathways | NA |
| Experiment | Biochemical Recurrence Free Survival |
| Type of Biomarker | Prognostic |
| Cohort | 20 PCa patients with recurrence and 118 without recurrence were included in this study |
| Senstivity | NA |
| Specificity | NA |
| AUC | NA |
| Accuracy | NA |
| Level Of Significance | p=0.025 |
| Method Used | RT-PCR |
| Clinical | No |
| Remarks | Biochemical recurrence was defined as a PSA level of ≥0.2 ng/mL |
| Clinical Trial Number | NA |
| Degree Of Validity | Not validated on independent patient dataset |
| Technical Name | TMPRSS2, ERG, TERT |